Page 112 - 南京医科大学学报自然科学版
P. 112
第43卷第10期
·1438 · 南 京 医 科 大 学 学 报 2023年10月
数据;EnhancerAtlas 数据库(http://www.enhancerat⁃ enhancer transcription and eRNAs in cancer[J]. Cancer
las.org/) 能够提供人、小鼠、果蝇等 9 个物种的增 Res,2021,81(16):4174-4182
[76]
强子注释;HACER 数据库(http://bioinfo.vanderbilt. [7] NAPOLI M,WU S J,GORE B L,et al. ΔNp63 regulates a
[77] common landscape of enhancer associated genes in non⁃
edu/AE/HACER/index.html) 可通过整合 GRO⁃seq
small cell lung cancer[J]. Nat Commun,2022,13(1):
数据分析 eRNA 鉴定活性增强子。此外,RAEdb 数
614
据 库(http://www.computationalbiology.cn/RAEdb/en⁃
[8] LI Q,LV X,HAN C,et al. Enhancer reprogramming pro⁃
hancer.html)汇集了 MPRA 和 STARR⁃seq 数据,可用
motes the activation of cancer⁃associated fibroblasts and
于筛选具有调控活性的增强子。
breast cancer metastasis[J]. Theranostics,2022,12
7 展 望 (17):7491-7508
[9] FAGNOCCHI L,POLI V,ZIPPO A. Enhancer reprogram⁃
增强子作为增强基因表达的顺式调控元件,其 ming in tumor progression:a new route towards cancer
活性异常在恶性肿瘤发生和发展中的重要作用已 cell plasticity[J]. Cell Mol Life Sci,2018,75(14):2537-
成为肿瘤研究领域的焦点之一。然而,尽管增强子 2555
研究在过去几十年中取得了显著进展,但这一领域 [10] PANIGRAHI A,O’MALLEY B W. Mechanisms of en⁃
仍有很多未知。例如,导致肿瘤基因组中增强子重 hancer action:the known and the unknown[J]. Genome
塑的因素有哪些?增强子重塑与肿瘤发生发展有 Biol,2021,22(1):108
[11] BALSALOBRE A,DROUIN J. Pioneer factors as master
何具体联系?增强子如何特异性地识别靶基因发
regulators of the epigenome and cell fate[J]. Nat Rev Mol
挥其调控功能?不同增强子之间如何相互协调,共
Cell Biol,2022,23(7):449-464
同调节下游靶基因的表达?不同肿瘤组织中增强
[12] ZHOU P,ZHANG Y,SETHI I,et al. GATA4 regulates de⁃
子调控活性异常的分子机制和生物学效应有何共 veloping endocardium through interaction with ETS1[J].
性和特异性?eRNA转录本蕴藏的生物学功能究竟 Circ Res,2022,131(11):e152-e168
有哪些?超级增强子是如何形成的?未来需要在 [13] BARRAL A,DÉJARDIN J. The chromatin signatures of
充分利用大数据和分子生物学技术的基础上,围绕 enhancers and their dynamic regulation[J]. Nucleus,
临床相关的增强子异常,利用体内模型开展深入的 2023,14(1):2160551
研究,从而更好地阐述增强子相关的基础理论和临 [14] MOHANTA T K,MISHRA A K,AL⁃HARRASI A.The 3D
床问题,这将有助于基础研究向临床转化,更好地 genome:from structure to function[J]. Int J Mol Sci,
促进肿瘤治疗和干预。 2021,22(21):11585
[15] LIU N Q,MARESCA M,VAN DEN BRAND T,et al.
[参考文献]
WAPL maintains a cohesin loading cycle to preserve cell⁃
[1] BANERJI J,RUSCONI S,SCHAFFNER W. Expression type⁃specific distal gene regulation[J]. Nat Genet,2021,
of a beta⁃globin gene is enhanced by remote SV40 DNA 53(1):100-109
sequences[J]. Cell,1981,27(2 Pt 1):299-308 [16] SEE Y X,CHEN K J,FULLWOOD M J. MYC overexpre⁃
[2] GILLIES S D,MORRISON S L,OI V T,et al. A tissue⁃ ssion leads to increased chromatin interactions at super⁃
specific transcription enhancer element is located in the enhancers and MYC binding sites[J]. Genome Res,2022,
major intron of a rearranged immunoglobulin heavy chain 32(4):629-642
gene[J]. Cell,1983,33(3):717-728 [17] GONG F R,SUN L,WANG Z D,et al. The BCL2 gene is
[3] DAVIS C A,HITZ B C,SLOAN C A,et al. The encyclope⁃ regulated by a special AT⁃rich sequence binding protein 1⁃
dia of DNA elements(ENCODE):data portal update[J]. mediated long range chromosomal interaction between the
Nucleic Acids Res,2018,46(D1):D794-D801 promoter and the distal element located within the 3’⁃
[4] SATTERLEE J S,CHADWICK L H,TYSON F L,et al. UTR[J]. Nucleic Acids Res,2011,39(11):4640-4652
The NIH Common Fund/Roadmap Epigenomics Program: [18] ZELENKA T,KLONIZAKIS A,TSOUKATOU D,et al.
successes of a comprehensive consortium[J]. Sci Adv, The 3D enhancer network of the developing T cell ge⁃
2019,5(7):eaaw6507 nome is shaped by SATB1[J]. Nat Commun,2022,13
[5] BRADNER J E,HNISZ D,YOUNG R A. Transcriptional (1):6954
addiction in cancer[J]. Cell,2017,168(4):629-643 [19] LEE J H,XIONG F,LI W. Enhancer RNAs in cancer:
[6] ADHIKARY S,ROY S,CHACON J,et al. Implications of regulation,mechanisms and therapeutic potential[J]. RNA